107 related articles for article (PubMed ID: 9661825)
1. Hepatosplenic tuberculosis: a cause of persistent fever during recovery from prolonged neutropenia.
Chakrabarti S; Varma S; Kochhar R; Gupta S; Gupta SK; Rajwanshi A
Int J Tuberc Lung Dis; 1998 Jul; 2(7):575-9. PubMed ID: 9661825
[TBL] [Abstract][Full Text] [Related]
2. Hepatosplenic candidiasis: an overlooked cause of prolonged fever during recovery from an episode of neutropenia.
Fenaux P; Lemaitre L; Ajana F; Colcher-Plantier I; Jouet JP; Bauters F
Nouv Rev Fr Hematol (1978); 1989; 31(1):45-9. PubMed ID: 2644620
[TBL] [Abstract][Full Text] [Related]
3. Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia.
Przepiorka D; Buadi FK; McClune B
Pharmacotherapy; 2008 Jan; 28(1):58-63. PubMed ID: 18154475
[TBL] [Abstract][Full Text] [Related]
4. Febrile neutropenia in haematological malignancies.
Sharma A; Lokeshwar N
J Postgrad Med; 2005; 51 Suppl 1():S42-8. PubMed ID: 16519255
[TBL] [Abstract][Full Text] [Related]
5. Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.
Raad II; Escalante C; Hachem RY; Hanna HA; Husni R; Afif C; Boktour MR; Whimbey EE; Kontoyiannis D; Jacobson K; Kantarjian H; Levett LM; Rolston KV
Cancer; 2003 Sep; 98(5):1039-47. PubMed ID: 12942573
[TBL] [Abstract][Full Text] [Related]
6. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
Yoshida M; Karasawa M; Naruse T; Fukuda M; Hirashima K; Oh H; Ninomiya H; Abe T; Saito K; Shishido H; Moriyama Y; Shibata A; Motoyoshi K; Nagata N; Miura Y
Int J Hematol; 1999 Feb; 69(2):81-8. PubMed ID: 10071455
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of granulocyte transfusions for neutropenia-related infections: retrospective analysis of predictive factors.
Rutella S; Pierelli L; Sica S; Serafini R; Chiusolo P; Paladini U; Leone F; Zini G; D'Onofrio G; Leone G; Piccirillo N
Cytotherapy; 2003; 5(1):19-30. PubMed ID: 12745586
[TBL] [Abstract][Full Text] [Related]
8. Neutropenic fever syndromes in patients undergoing cytotoxic therapy for acute leukemia and myelodysplastic syndromes.
Bow EJ
Semin Hematol; 2009 Jul; 46(3):259-68. PubMed ID: 19549578
[TBL] [Abstract][Full Text] [Related]
9. Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: a prospective randomized trial.
Harter C; Schulze B; Goldschmidt H; Benner A; Geiss HK; Hoppe-Tichy T; Ho AD; Egerer G
Bone Marrow Transplant; 2006 Feb; 37(4):373-9. PubMed ID: 16400334
[TBL] [Abstract][Full Text] [Related]
10. Bloodstream infections in febrile neutropenic patients: bacterial spectrum and antimicrobial susceptibility pattern.
Butt T; Afzal RK; Ahmad RN; Salman M; Mahmood A; Anwar M
J Ayub Med Coll Abbottabad; 2004; 16(1):18-22. PubMed ID: 15125174
[TBL] [Abstract][Full Text] [Related]
11. [Fever in the neutropenic patient].
Milpied N
Rev Prat; 2001 Mar; 51(6):633-7. PubMed ID: 11345865
[TBL] [Abstract][Full Text] [Related]
12. Mucocutaneous findings in febrile neutropenic children with acute leukemias.
Wananukul S; Nuchprayoon I; Siripanich H
J Med Assoc Thai; 2005 Jun; 88(6):817-23. PubMed ID: 16083222
[TBL] [Abstract][Full Text] [Related]
13. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
Tamura K
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
[TBL] [Abstract][Full Text] [Related]
14. Laparoscopic intervention in resistant hepatosplenic tuberculosis presenting as pyrexia of unknown origin.
D'Cruz K; Angamuthu N; Anand J; D'Souza G
Trop Gastroenterol; 2005; 26(1):40-2. PubMed ID: 15974239
[TBL] [Abstract][Full Text] [Related]
15. Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey.
Cornillet A; Camus C; Nimubona S; Gandemer V; Tattevin P; Belleguic C; Chevrier S; Meunier C; Lebert C; Aupée M; Caulet-Maugendre S; Faucheux M; Lelong B; Leray E; Guiguen C; Gangneux JP
Clin Infect Dis; 2006 Sep; 43(5):577-84. PubMed ID: 16886149
[TBL] [Abstract][Full Text] [Related]
16. Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications.
Klastersky J; Paesmans M; Georgala A; Muanza F; Plehiers B; Dubreucq L; Lalami Y; Aoun M; Barette M
J Clin Oncol; 2006 Sep; 24(25):4129-34. PubMed ID: 16943529
[TBL] [Abstract][Full Text] [Related]
17. Cefepime plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
Hamidah A; Lim YS; Zulkifli SZ; Zarina AL; Nordiah AJ; Jamal R
Singapore Med J; 2007 Jul; 48(7):615-9. PubMed ID: 17609821
[TBL] [Abstract][Full Text] [Related]
18. Hepatosplenic tuberculosis mimicking disseminated candidiasis in patients with acute leukemia.
Lee DG; Choi JH; Kim YJ; Lee S; Min CK; Kim DW; Lee JW; Min WS; Shin WS; Kim CC
Int J Hematol; 2001 Jan; 73(1):119-21. PubMed ID: 11372747
[TBL] [Abstract][Full Text] [Related]
19. Risk index for predicting complications and prognosis in Thai patients with neutropenia and fever.
Chayakulkeeree M; Thamlikitkul V
J Med Assoc Thai; 2003 Mar; 86(3):212-23. PubMed ID: 12757060
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and therapeutic outcome of patients with febrile neutropenia who present in shock: need for better strategies.
Malik I; Hussain M; Yousuf H
J Infect; 2001 Feb; 42(2):120-5. PubMed ID: 11531318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
